ViroCell Biologics
Home
Conferences Careers Contact Us
Leadership Team Scientific Advisory Board Board of Directors
Innovation Research Vector design & optimization Process Development GMP manufacturing
In the News Press Releases
Home Who We Are Leadership Team Scientific Advisory Board Board of Directors What we do Innovation Research Vector design & optimization Process Development GMP manufacturing
ViroCell Biologics
Conferences Newsroom In the News Press Releases CareersContact Us

ViroCell Adds J. David Enloe And Dr. Martin Pule To Its Board Of Directors

MORE
In the NewsFlorence BuchananSeptember 6, 2021CDMO, ViroCell Board of Directors, Scientific Advisory Board, J. David Enloe, Martin Pule, Life Sciences Review, UK CDMO, viral vectors, vector design
LinkedIn0 0 Likes
Previous

ViroCell Biologics and Great Ormond Street Hospital for Children Announce Partnership to Dislodge Gene and Cell Therapy “Logjam”

In the NewsFlorence BuchananSeptember 28, 2021CDMO, GOSH, Zayed Centre for Research, clean rooms, cell and gene therapies, 1L to 200L batch size, viral vectors, lentivirus vector, AAV vectors, CGT, cell therapy, gene therapy, UK CDMO, NHS Foundation Trust, Great Ormond Street Hospital, vector design, Pharmtech Focus
Next

BioSpace Movers & Shakers

In the NewsFlorence BuchananAugust 20, 2021ViroCell Board of Directors, Scientific Advisory Board, David Enloe, Lonza, University College London, gene therapy, cell therapy, CGT, viral vectors, European Patent Office, University College Hospital, Recro Pharma, BioSpace
NewsroomCareersContact UsTerms of UsePrivacy Notice

London New York

 

©2024 ViroCell Biologics, Ltd. All rights reserved.